Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)'s share was trading at $109.09 as of Nov 11^th. NVO’s trailing and forward P/E were 35.82 and 27.70 respectively according to Yahoo Finance.

[caption id="attachment_1238936" align="aligncenter" width="768"] A closeup of pills in a pharmacy, representing the high quality medications of the company.[/caption]

Novo Nordisk (NVO) is offering a unique opportunity for investors who may have...